Ignite Creation Date:
2025-12-24 @ 4:13 PM
Ignite Modification Date:
2025-12-27 @ 12:33 PM
Study NCT ID:
NCT06816966
Status:
ENROLLING_BY_INVITATION
Last Update Posted:
2025-02-10
First Post:
2025-01-16
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Chemotherapy-immunotherapy-based Split-course Adaptive Hypofractionated Radiotherapy for Extensive-stage SCLC
Sponsor:
Fujian Medical University Union Hospital
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-12-26
Start Date Type:
ACTUAL
Primary Completion Date:
2026-10-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2028-10-31
Completion Date Type:
ESTIMATED
First Submit Date:
2025-01-16
First Submit QC Date:
None
Study First Post Date:
2025-02-10
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-02-06
Last Update Post Date:
2025-02-10
Last Update Post Date Type:
ACTUAL